Showing results (121-130 of 139) with videos related to
Sort By:
Pageof 14
Acta Ophthalmologica|November 30, 2021
Treat-and-extend regimens of anti-vascular endothelial growth factor therapy for retinal vein occlusions: a systematic review and meta-analysisKeean Nanji, Mohammad Khan, Muhammad F Khalid, et al.ACS Chemical Biology|January 4, 2022
Repurposing the Damage Repair Protein Methyl Guanine Methyl Transferase as a Ligand Inducible Fusion DegronGosia M Murawska, Caspar Vogel, Max Jan, et al.Leukemia & Lymphoma|November 21, 2015
Cost-effectiveness of rituximab in addition to fludarabine and cyclophosphamide (R-FC) for the first-line treatment of chronic lymphocytic leukemiaDirk Müller, Kirsten Fischer, Peter Kaiser, et al.Frontiers in Genetics|November 16, 2020
Integrating Genetic and Genomic Analyses of Combined Health Data Across Ecotypes to Improve Disease Resistance in Indigenous African ChickensGeorgios Banos, Victoria Lindsay, Takele T Desta, et al.Biomolecules|August 29, 2024
Pyrimidine Triones as Potential Activators of p53 MutantsMaryam M Jebril Fallatah, Özlem Demir, Fiona Law, et al.Plos One|December 16, 2025
OphthoEvidence report: Baseline structural optical coherence tomography biomarkers predictive of visual acuity following epiretinal membrane surgery-A systematic review and meta-analysis protocolXiajing Chu, João Pedro Lima, Dena Zeraatkar, et al.Ophthalmology|December 6, 2021
The 12- and 24-Month Effects of Intravitreal Ranibizumab, Aflibercept, and Bevacizumab on Intraocular Pressure: A Network Meta-AnalysisKeean Nanji, Gurkaran S Sarohia, Kevin Kennedy, et al.Nature Communications|January 31, 2013
Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53Christopher D Wassman, Roberta Baronio, Özlem Demir, et al.International Journal of Cancer|January 26, 2017
Immunohistochemical detection of lymph node-DTCs in patients with node-negative HNSCCChristoph Sproll, Anna Karen Freund, Andrea Hassel, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 15, 2020
Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosisRobert A Bermel, Janel K Fedler, Peter Kaiser, et al.Pageof 14